Clinical Trial

Neoadjuvant Chemoimmunotherapy or Chemoradiotherapy in ESCC

Name: Neoadjuvant Chemoimmunotherapy or Chemoradiotherapy in ESCC — clinical trial record (NCT07385664)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: FAIR

Not Yet Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

This study was a single-arm, two-cohort, phase II trial aimed at evaluating the efficacy and safety of FAPI-PET/CT response for guiding the selection of neoadjuvant treatment modes after chemotherapy combined with immunotherapy.

Trial Details

NCT Number	NCT07385664
Lead Sponsor	Ji Yongling
Conditions	Resectable Esophageal Cancer
Enrollment	66 participants
Start Date	2026-01-28
Primary Completion	2027-01-30 (estimated)
Study Completion	2028-02-01 (estimated)
Updated on ClinicalTrials.gov	2026-02-04